3 Great Shares For A Beginners’ Portfolio: GlaxoSmithKline plc, Schroders plc & Latchways plc

GlaxoSmithKline plc (LON:GSK), Schroders plc (LON:SDR) and Latchways plc (LON:LTC) are three shares that could help transform your wealth.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

gskMulti-billionaire Warren Buffett, probably the world’s most famous and successful investor, follows a strategy of buying great businesses with a view to holding his shares ‘forever’.

What’s good enough for octogenarian Buffett should be good enough for an investor just starting out on the road to long-term wealth accumulation.

Today, I’m going to tell you why I think GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US), Schroders (LSE: SDR) and Latchways (LSE: LTC) are worth consideration for a beginner’s portfolio.

GlaxoSmithKline

Pharmaceuticals giant GlaxoSmithKline has a market capitalisation of £70bn, and is the fourth-largest company in the FTSE 100. The company is a ‘core’ holding for many investors.

Size, prodigious cash generation and the ‘non-cyclical’ nature of the pharma industry make Glaxo a relatively steady share through all economic conditions. The company has a great dividend history, and the prospective dividend yield is currently 5.7% at a share price of 1,434p. Reinvest the dividends to buy more shares year after year and the value of your investment should snowball over the long term.

Schroders 

Asset manager Schroders (founded in 1804) is also in the FTSE 100. With a market capitalisation of £6.5bn, Schroders may not be in the ‘megacap’ league of Glaxo, but I believe it has attractions for long-term investors.

The nature of Schroders’ business means its shares tend to exaggerate the returns of the wider market. Shareholders have to steel themselves when markets wobble, but because markets rise over the long term (multi-decades) the reward should be outsize returns if Schroders continues to do what it’s done successfully for over 200 years.

Unusually, the company has two classes of share: voting shares (ticker SDR) and non-voting shares (LSE: SDRC). Small private investors have little to gain from holding the voting shares. The non-voting shares are cheaper (currently 1,851p versus 2,435p for the voting shares), and provide a bigger dividend yield: 3.7% versus 2.8%.

Latchways

Smaller companies are considered inherently more risky than big companies — but they also have potential to grow faster. Furthermore, some smaller businesses have the kind of qualities Buffett looks for, and even a beginner may want to consider including a smattering of such shares in a portfolio.

Latchways, which has a market capitalisation of £109m, is the global leader in fall protection equipment for people working at height. Safety is not something employers can afford to skimp on. Latchways’ reputation as the number one — built over 30 years — and increasing safety regulation around the world, give the company plenty of scope to continue growing strongly.

Recent cyclical weakness is some of Latchways’ markets, notably commercial construction in parts of Europe, means investors today can buy the shares at a lower price (965p) than would otherwise have been the case. It also means that the prospective dividend yield (4.4%) is higher than usual.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. The Motley Fool UK owns shares of Latchways. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Dividend Shares

Prediction: the Lloyds share price could hit £1.25 in 2026

The Lloyds share price has had a splendid 2025 and is inching closer to the elusive £1 mark. But what…

Read more »

Long-term vs short-term investing concept on a staircase
Investing Articles

Here’s how much you need in an ISA of UK stocks to target £2,700 in monthly dividend income

To demonstrate the benefits of investing in dividend-paying UK stocks, Mark Hartley calculates how much to put in an ISA…

Read more »

photo of Union Jack flags bunting in local street party
Investing Articles

Is the FTSE 250 set for a rip-roaring comeback in 2026?

With the FTSE 250 index trading very cheaply, Ben McPoland reckons this market-leading tech stock's worthy of attention in 2026.

Read more »

Young Caucasian man making doubtful face at camera
Dividend Shares

Will the Diageo share price crash again in 2026?

The Diageo share price has crashed 35.6% over one year, making it one of the FTSE 100's worst performers in…

Read more »

Investing Articles

Is Alphabet still one of the best shares to buy heading into 2026?

The best time to buy shares is when other investors are seeing risks. Is that the case with Google’s parent…

Read more »

Investing Articles

Could the Barclays share price be the FTSE 100’s big winner in 2026?

With OpenAI and SpaceX considering listing on the stock market, could investment banking revenues push the Barclays share price higher…

Read more »

Investing Articles

Will the Nvidia share price crash in 2026? Here are the risks investors can’t ignore

Is Nvidia’s share price in danger in 2026? Stephen Wright outlines the risks – and why some might not be…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Growth Shares

I asked ChatGPT how much £10,000 invested in Lloyds shares 5 years ago is worth today? But it wasn’t very helpful…

Although often impressive, artificial intelligence has its flaws. James Beard found this out when he used it to try and…

Read more »